Management of patients with persistent beta-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy

Int J Gynaecol Obstet. 1994 Oct;47(1):33-8. doi: 10.1016/0020-7292(94)90458-8.

Abstract

Objectives: To show that the beta-human chorionic gonadotropin (hCG) decline following tubal-preserving techniques for ectopic pregnancy (EP) can take a longer course than currently believed, indicating expectant management; and to define the indications for a second-look laparoscopy if beta-hCG persists.

Methods: Three hundred thirty-seven patients treated for EP were retrospectively reviewed. In order to define the 'normal' beta-hCG decline following tubal-preserving techniques we acquired a Kaplan-Meier curve for 98 patients treated by laparoscopic linear salpingotomy, the main method performed for EP (253 patients). The Mann-Whitney U-test served as a statistical test. The patient population requiring a second-look laparoscopy for proliferating trophoblastic remnants is described.

Results: Twenty-eight patients (8.3%) required a second-look laparoscopy (acute abdominal pain and sonographically suspect findings combined with increasing beta-hCG values). The majority (15 patients) underwent a preceding laparoscopic linear salpingotomy (6.5% unresolved cases). The relative beta-hCG values differed significantly from the unresolved group compared to the group with resolved EP starting at postoperative day 2 (P < 0.01). A maximal beta-hCG decline period of 77 days postoperatively was observed.

Conclusions: Patients with slowly declining beta-hCG levels following tubal-preserving techniques for EP can be managed expectantly. Increasing beta-hCG values combined with abdominal pain and sonographically suspect observations indicate a second-look laparoscopy.

MeSH terms

  • Chorionic Gonadotropin / blood*
  • Chorionic Gonadotropin, beta Subunit, Human
  • Female
  • Follow-Up Studies
  • Humans
  • Laparoscopy
  • Methotrexate / therapeutic use
  • Ornipressin / therapeutic use
  • Peptide Fragments / blood*
  • Pregnancy
  • Pregnancy, Tubal / blood
  • Pregnancy, Tubal / epidemiology
  • Pregnancy, Tubal / therapy*
  • Reoperation
  • Retrospective Studies
  • Time Factors

Substances

  • Chorionic Gonadotropin
  • Chorionic Gonadotropin, beta Subunit, Human
  • Peptide Fragments
  • Ornipressin
  • Methotrexate